A detailed history of Saturna Capital Corp transactions in Rx Sight, Inc. stock. As of the latest transaction made, Saturna Capital Corp holds 9,618 shares of RXST stock, worth $321,529. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,618
Previous 9,618 -0.0%
Holding current value
$321,529
Previous $578,000 17.82%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$50.42 - $64.29 $70,588 - $90,006
-1,400 Reduced 12.71%
9,618 $578,000
Q4 2023

Feb 06, 2024

SELL
$20.91 - $40.9 $6,377 - $12,474
-305 Reduced 2.69%
11,018 $444,000
Q3 2023

Nov 14, 2023

BUY
$27.05 - $33.37 $29,755 - $36,707
1,100 Added 10.76%
11,323 $315,000
Q2 2023

Aug 04, 2023

BUY
$16.37 - $28.9 $167,350 - $295,444
10,223 New
10,223 $294,000
Q2 2022

Aug 12, 2022

BUY
$10.61 - $16.66 $152,784 - $239,904
14,400 New
14,400 $203,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $924M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Saturna Capital Corp Portfolio

Follow Saturna Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.